Top Markets
Coin of the day
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
Rank in Stocks #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Share Price
$1.58
Last synced: 2026-08-21
Market Cap
$71.95M
Change (1 day)
0.64%
Change (1 year)
-36.29%
Country
US
Trade OS Therapies Incorporated (OSTX)

Category

Number of shares outstanding for OS Therapies Incorporated (OSTX)
Number of shares outstanding as of August 2026: 0
According to OS Therapies Incorporated latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for OS Therapies Incorporated (OSTX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
396.00M -
US
478.91M -
AU
- -
CH